Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Galera Therapeutics, Inc. (GRTX) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Galera Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1563577.
Total stock buying since 2019: $29,795,097.
Total stock sales since 2019: $20,156,921.
Total stock option exercises since 2019: $197,297.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 932,402 | $166,156 | 67,015 | $4,825 | 0 | $0 |
| 2023 | 121,000 | $212,407 | 0 | $0 | 0 | $0 |
| 2021 | 54,045 | $353,632 | 547,756 | $5,694,493 | 67,756 | $137,447 |
| 2020 | 2,325 | $23,770 | 1,573,391 | $14,457,603 | 48,285 | $59,850 |
| 2019 | 2,420,666 | $29,039,132 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-08 | 0 | $0 | 67,015 | $4,825 | 0 | $0 |
| 2024-02 | 447,402 | $78,521 | 0 | $0 | 0 | $0 |
| 2024-01 | 485,000 | $87,635 | 0 | $0 | 0 | $0 |
| 2023-03 | 121,000 | $212,407 | 0 | $0 | 0 | $0 |
| 2021-12 | 20,000 | $54,800 | 0 | $0 | 20,000 | $21,400 |
| 2021-09 | 0 | $0 | 47,756 | $404,493 | 47,756 | $116,047 |
| 2021-06 | 24,045 | $212,422 | 0 | $0 | 0 | $0 |
| 2021-05 | 10,000 | $86,410 | 0 | $0 | 0 | $0 |
| 2021-02 | 0 | $0 | 500,000 | $5,290,000 | 0 | $0 |
| 2020-11 | 2,325 | $23,770 | 20,000 | $203,830 | 20,000 | $26,170 |
| 2020-10 | 0 | $0 | 462,880 | $5,111,292 | 12,880 | $17,201 |
| 2020-06 | 0 | $0 | 1,075,106 | $8,957,129 | 0 | $0 |
| 2020-05 | 0 | $0 | 15,405 | $185,352 | 15,405 | $16,479 |
| 2019-12 | 4,000 | $39,140 | 0 | $0 | 0 | $0 |
| 2019-11 | 2,416,666 | $28,999,992 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-16 | Sorensen Mel (President and CEO) | Sale | 67,015 | .07 | 4,825 |
| 2024-02-08 | Schneid Yair | Buy | 150,000 | .17 | 25,650 |
| 2024-02-07 | Schneid Yair | Buy | 175,000 | .17 | 29,925 |
| 2024-02-06 | Schneid Yair | Buy | 25,000 | .20 | 5,025 |
| 2024-02-05 | Schneid Yair | Buy | 97,402 | .18 | 17,921 |
| 2024-01-30 | Schneid Yair | Buy | 335,000 | .18 | 60,635 |
| 2024-01-29 | Schneid Yair | Buy | 150,000 | .18 | 27,000 |
| 2023-03-16 | Bachleda Mark (Chief Commercial Officer) | Buy | 11,000 | 2.25 | 24,717 |
| 2023-03-13 | Degnan Chris (Chief Financial Officer) | Buy | 10,000 | 1.96 | 19,590 |
| 2023-03-10 | Sorensen Mel (President and CEO) | Buy | 100,000 | 1.68 | 168,100 |
| 2021-12-17 | West Linda (Director) | Buy | 20,000 | 2.74 | 54,800 |
| 2021-12-17 | Beardsley Robert A (Chief Operating Officer) | Option Ex | 20,000 | 1.07 | 21,400 |
| 2021-09-01 | Holmlund Jon T (Chief Medical Officer) | Sale | 47,756 | 8.47 | 404,493 |
| 2021-09-01 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 47,756 | 2.43 | 116,047 |
| 2021-06-15 | West Linda (Director) | Buy | 10,000 | 9.13 | 91,300 |
| 2021-06-01 | West Linda (Director) | Buy | 10,000 | 8.64 | 86,380 |
| 2021-06-01 | Alleva Lawrence M (Director) | Buy | 4,045 | 8.59 | 34,742 |
| 2021-05-28 | West Linda (Director) | Buy | 10,000 | 8.64 | 86,410 |
| 2021-02-18 | Novo Holdings A/s (10% Owner) | Sale | 500,000 | 10.58 | 5,290,000 |
| 2020-11-13 | Sussman Joel F. (Chief Accounting Officer) | Sale | 10,000 | 10.32 | 103,200 |
| 2020-11-13 | Sussman Joel F. (Chief Accounting Officer) | Option Ex | 10,000 | 1.55 | 15,470 |
| 2020-11-13 | Alleva Lawrence M (Director) | Buy | 2,325 | 10.22 | 23,770 |
| 2020-11-12 | Sussman Joel F. (Chief Accounting Officer) | Sale | 10,000 | 10.06 | 100,630 |
| 2020-11-12 | Sussman Joel F. (Chief Accounting Officer) | Option Ex | 10,000 | 1.07 | 10,700 |
| 2020-10-26 | Holmlund Jon T (Chief Medical Officer) | Sale | 2,244 | 15.00 | 33,660 |
| 2020-10-26 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 2,244 | 2.43 | 5,452 |
| 2020-10-15 | Novo Holdings A/s (10% Owner) | Sale | 450,000 | 11.00 | 4,950,000 |
| 2020-10-06 | Holmlund Jon T (Chief Medical Officer) | Sale | 10,536 | 12.00 | 126,432 |
| 2020-10-06 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 10,536 | 1.10 | 11,642 |
| 2020-10-05 | Holmlund Jon T (Chief Medical Officer) | Sale | 100 | 12.00 | 1,200 |
| 2020-10-05 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 100 | 1.07 | 107 |
| 2020-06-19 | Novartis Ag (Other) | Sale | 1,001,312 | 8.25 | 8,260,824 |
| 2020-06-18 | Novartis Ag (Other) | Sale | 900 | 9.04 | 8,135 |
| 2020-06-17 | Novartis Ag (10% Owner) | Sale | 4,622 | 9.27 | 42,845 |
| 2020-06-16 | Novartis Ag (10% Owner) | Sale | 8,600 | 9.30 | 79,980 |
| 2020-06-15 | Novartis Ag (10% Owner) | Sale | 6,164 | 9.05 | 55,784 |
| 2020-06-12 | Novartis Ag (10% Owner) | Sale | 1,500 | 9.19 | 13,785 |
| 2020-06-11 | Novartis Ag (10% Owner) | Sale | 7,200 | 9.21 | 66,312 |
| 2020-06-10 | Novartis Ag (10% Owner) | Sale | 8,532 | 9.46 | 80,712 |
| 2020-06-09 | Novartis Ag (10% Owner) | Sale | 7,000 | 9.38 | 65,660 |
| 2020-06-08 | Novartis Ag (10% Owner) | Sale | 5,659 | 9.66 | 54,665 |
| 2020-06-05 | Novartis Ag (10% Owner) | Sale | 8,652 | 9.66 | 83,578 |
| 2020-06-04 | Novartis Ag (10% Owner) | Sale | 4,088 | 9.55 | 39,040 |
| 2020-06-03 | Novartis Ag (10% Owner) | Sale | 5,208 | 9.78 | 50,934 |
| 2020-06-02 | Novartis Ag (10% Owner) | Sale | 5,669 | 9.68 | 54,875 |
| 2020-05-26 | Holmlund Jon T (Chief Medical Officer) | Sale | 692 | 12.00 | 8,304 |
| 2020-05-26 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 692 | 1.07 | 740 |
| 2020-05-21 | Holmlund Jon T (Chief Medical Officer) | Sale | 1,174 | 12.00 | 14,088 |
| 2020-05-21 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 1,174 | 1.07 | 1,256 |
| 2020-05-20 | Holmlund Jon T (Chief Medical Officer) | Sale | 969 | 12.00 | 11,628 |
| 2020-05-20 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 969 | 1.07 | 1,036 |
| 2020-05-12 | Holmlund Jon T (Chief Medical Officer) | Sale | 671 | 12.00 | 8,052 |
| 2020-05-12 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 671 | 1.07 | 717 |
| 2020-05-11 | Holmlund Jon T (Chief Medical Officer) | Sale | 185 | 12.00 | 2,220 |
| 2020-05-11 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 185 | 1.07 | 197 |
| 2020-05-08 | Holmlund Jon T (Chief Medical Officer) | Sale | 5,102 | 12.00 | 61,224 |
| 2020-05-08 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 5,102 | 1.07 | 5,459 |
| 2020-05-07 | Holmlund Jon T (Chief Medical Officer) | Sale | 2,059 | 12.00 | 24,710 |
| 2020-05-07 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 2,059 | 1.07 | 2,203 |
| 2020-05-06 | Holmlund Jon T (Chief Medical Officer) | Sale | 1,489 | 12.00 | 17,868 |
| 2020-05-06 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 1,489 | 1.07 | 1,593 |
| 2020-05-05 | Holmlund Jon T (Chief Medical Officer) | Sale | 3,064 | 12.16 | 37,258 |
| 2020-05-05 | Holmlund Jon T (Chief Medical Officer) | Option Ex | 3,064 | 1.07 | 3,278 |
| 2019-12-13 | Alleva Lawrence M (Director) | Buy | 4,000 | 9.79 | 39,140 |
| 2019-11-12 | Clarus Iv Gp L.p. (10% Owner) | Buy | 250,000 | 12.00 | 3,000,000 |
| 2019-11-12 | Mehra Anand (10% Owner) | Buy | 750,000 | 12.00 | 9,000,000 |
| 2019-11-12 | Novo Holdings A/s (Other) | Buy | 500,000 | 12.00 | 6,000,000 |
| 2019-11-12 | Sandell Scott D (10% Owner) | Buy | 416,666 | 12.00 | 4,999,992 |
| 2019-11-12 | Novartis Ag (10% Owner) | Buy | 250,000 | 12.00 | 3,000,000 |
| 2019-11-12 | Schwarzman Stephen A (10% Owner) | Buy | 250,000 | 12.00 | 3,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of GRTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Galera Therapeutics, Inc. (symbol GRTX, CIK number 1563577) see the Securities and Exchange Commission (SEC) website.